MaxCyte Acquires SeQure Dx to Broaden Cell Engineering Offerings with On-target and Off-target Editing Assessments
January 30, 2025 02:00 ET | Source: MaxCyte, Inc ROCKVILLE, Md., Jan.…
MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results
January 13, 2025 03:05 ET | Source: MaxCyte, Inc ROCKVILLE, Md., Jan.…
MaxCyte Announces Retirement of Board Member Art Mandell
December 23, 2024 02:00 ET | Source: MaxCyte, Inc ROCKVILLE, Md., Dec.…